CIMG Reports Significant Revenue Growth in Q4 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy IMG?
Source: Newsfilter
- Significant Revenue Growth: CIMG achieved revenue of $15,768,796 in Q4 2025, a substantial increase from $22,853 in the same period of 2024, reflecting strong early-stage commercialization of its medicine-food homology products and computing power solutions, indicating the potential of new business lines.
- Digital Asset Expansion: As of December 31, 2025, the company held 730 Bitcoins with a carrying value of $63,978,821, demonstrating the effectiveness of its investment strategy in digital assets and enhancing its financial stability.
- Accelerated Global Layout: During Q4 2025, CIMG established wholly-owned subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary, significantly improving its production, sales, and R&D capabilities in the Asian market, thereby strengthening localized operational advantages.
- Ongoing Strategic Transformation: CIMG will continue to focus on a dual-track strategy for health consumer goods and computing power technology products, planning to optimize product pricing and cost control while increasing R&D investment in computing power products to enhance gross margins and expand its enterprise customer base.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IMG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IMG
About IMG
CIMG Inc., formerly NuZee, Inc., is a digital marketing, sales and distribution company for various consumer products with focuses on food and beverages. The Company focuses on specialty coffee and technologies. The Company's products include single serve pour over, coffee brew bag coffee products, and single serve coffee format, DRIPKIT pour over products. Its DRIPKIT pour over format features a large-size single serve pour over pack that sits on top of the cup and delivers to its customers in the United States, Canada and Mexico. The Company also sells single serve coffee products, including its flagship Coffee Blenders line of both single serves pour over coffee and coffee brew bag coffee products. Coffee Blenders also offers Coldpresso latte product line that is available to purchase in Korea and online. The Company sells its Twin Peaks single serve pour over coffee exclusively via Amazon. It has a sales and distribution network for maca infused food and beverages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CIMG Reports Significant Revenue Growth in Q4 2025 Financial Results
- Significant Revenue Growth: CIMG reported total revenue of $15.77 million for Q4 2025, a substantial increase from $22,853 in the same period of 2024, reflecting the company's successful early-stage commercialization in medicine-food homology products and computing power solutions, thereby enhancing its market competitiveness.
- Digital Asset Expansion: As of December 31, 2025, the company held 730 Bitcoins with a carrying value of $63.98 million, indicating a strategic positioning in the digital asset space that bolsters its financial stability.
- Accelerated Global Layout: In Q4 2025, CIMG established wholly-owned subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary, optimizing its production, sales, and R&D layout in the Asian market while strengthening localized operational capabilities.
- Ongoing Strategic Transformation: CIMG will continue to focus on the Asia market, deepening its dual-track strategy in health consumer goods and computing power technology products, with plans to enhance gross profit margins through optimized pricing and cost control, although the success of these efforts remains uncertain.
See More
CIMG Reports Significant Revenue Growth in Q4 2025 Financial Results
- Significant Revenue Growth: CIMG achieved revenue of $15,768,796 in Q4 2025, a substantial increase from $22,853 in the same period of 2024, reflecting strong early-stage commercialization of its medicine-food homology products and computing power solutions, indicating the potential of new business lines.
- Digital Asset Expansion: As of December 31, 2025, the company held 730 Bitcoins with a carrying value of $63,978,821, demonstrating the effectiveness of its investment strategy in digital assets and enhancing its financial stability.
- Accelerated Global Layout: During Q4 2025, CIMG established wholly-owned subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary, significantly improving its production, sales, and R&D capabilities in the Asian market, thereby strengthening localized operational advantages.
- Ongoing Strategic Transformation: CIMG will continue to focus on a dual-track strategy for health consumer goods and computing power technology products, planning to optimize product pricing and cost control while increasing R&D investment in computing power products to enhance gross margins and expand its enterprise customer base.
See More
CIMG Enters Strategic Partnership MOU with iZUMi
- Strategic Partnership MOU: CIMG has signed a memorandum of understanding with iZUMi to explore broader cooperation in digital asset infrastructure and on-chain liquidity services, indicating a strong intent for future collaboration.
- Potential Asset Acquisition: Under the MOU, CIMG may acquire certain assets, patents, and technologies from iZUMi, which could enhance CIMG's capabilities in managing its digital assets, particularly its Bitcoin holdings.
- Digital Asset Strategy: CIMG aims to evaluate new ways to manage and utilize its digital assets through this partnership, further driving growth in its digital health and sales development sectors.
- Client Portfolio Expansion: CIMG's client portfolio includes brands like Kangduoyuan and Maca-Noni, and this collaboration is expected to enhance its commercial value and market competitiveness by integrating iZUMi's services and IZI tokens.
See More
CIMG Enters Strategic Partnership MOU with iZUMi Finance
- Strategic Partnership MOU: CIMG has signed a memorandum of understanding with iZUMi Finance to explore extensive cooperation in digital asset infrastructure and on-chain liquidity services, indicating a strong intent for future collaboration between the parties.
- Potential Asset Acquisition: Under the MOU, CIMG may acquire certain assets, patents, and technologies from iZUMi, which would enhance CIMG's competitiveness in the digital health and sales development sectors.
- Digital Asset Management: CIMG intends to evaluate ways to manage and utilize its digital assets, including Bitcoin holdings, through this partnership, thereby increasing its commercial value and market position.
- Client Portfolio Expansion: CIMG focuses on leveraging AI and cryptocurrencies to drive business growth, with existing clients including several well-known brands, and future collaborations are expected to further expand its client base and market influence.
See More
CIMG Reports Significant Revenue Growth in FY 2025 Financial Results
- Significant Revenue Growth: CIMG achieved substantial revenue growth in FY 2025, driven by optimizing its business structure and focusing on two core sectors: AI computing infrastructure and digital health, demonstrating the effectiveness of the company's strategic transformation.
- Continued Reduction in Net Loss: The company reported a continued reduction in net loss during the reporting period, reflecting positive outcomes from the launch of new businesses and the progress of major contracts, alongside refined management practices.
- Digital Asset Strategy: CIMG plans to increase its Bitcoin holdings based on market conditions to strengthen corporate assets and core competitiveness, aiming to create sustainable value for shareholders, customers, and partners.
- Diverse Client Portfolio: The company's current client portfolio includes various brands such as Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango, showcasing its broad influence in the digital health and sales development sectors.
See More
CIMG Reports Significant Revenue Growth in FY 2025
- Significant Revenue Growth: CIMG reported approximately $10.3 million in revenue for FY 2025, reflecting a remarkable year-on-year increase of 433%, primarily driven by new computing power service contracts and its digital health business, indicating strong market performance.
- Substantial Reduction in Net Loss: The company's net loss decreased by approximately 45.5% year-on-year, showcasing the effectiveness of its business transformation and cost optimization efforts, which highlight significant progress in operational efficiency.
- Increased Digital Asset Reserves: As of September 30, 2025, CIMG held around 500 Bitcoins valued at approximately $57.05 million, contributing to a staggering 1,227% year-on-year increase in total assets, demonstrating the success of its digital asset strategy.
- Enhanced Shareholder Value: With a book value per share of approximately $2.99, combined with the company's strategic focus on AI computing infrastructure and digital health, it is expected to create sustainable value for shareholders, customers, and partners.
See More
CIMG Reports Significant Revenue Growth in Q4 2025 Financial Results
- Significant Revenue Growth: CIMG reported total revenue of $15.77 million for Q4 2025, a substantial increase from $22,853 in the same period of 2024, reflecting the company's successful early-stage commercialization in medicine-food homology products and computing power solutions, thereby enhancing its market competitiveness.
- Digital Asset Expansion: As of December 31, 2025, the company held 730 Bitcoins with a carrying value of $63.98 million, indicating a strategic positioning in the digital asset space that bolsters its financial stability.
- Accelerated Global Layout: In Q4 2025, CIMG established wholly-owned subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary, optimizing its production, sales, and R&D layout in the Asian market while strengthening localized operational capabilities.
- Ongoing Strategic Transformation: CIMG will continue to focus on the Asia market, deepening its dual-track strategy in health consumer goods and computing power technology products, with plans to enhance gross profit margins through optimized pricing and cost control, although the success of these efforts remains uncertain.
See More
CIMG Reports Significant Revenue Growth in Q4 2025 Financial Results
- Significant Revenue Growth: CIMG achieved revenue of $15,768,796 in Q4 2025, a substantial increase from $22,853 in the same period of 2024, reflecting strong early-stage commercialization of its medicine-food homology products and computing power solutions, indicating the potential of new business lines.
- Digital Asset Expansion: As of December 31, 2025, the company held 730 Bitcoins with a carrying value of $63,978,821, demonstrating the effectiveness of its investment strategy in digital assets and enhancing its financial stability.
- Accelerated Global Layout: During Q4 2025, CIMG established wholly-owned subsidiaries in Shenzhen and Foshan, China, and acquired Braincon Limited and its subsidiary, significantly improving its production, sales, and R&D capabilities in the Asian market, thereby strengthening localized operational advantages.
- Ongoing Strategic Transformation: CIMG will continue to focus on a dual-track strategy for health consumer goods and computing power technology products, planning to optimize product pricing and cost control while increasing R&D investment in computing power products to enhance gross margins and expand its enterprise customer base.
See More
CIMG Enters Strategic Partnership MOU with iZUMi
- Strategic Partnership MOU: CIMG has signed a memorandum of understanding with iZUMi to explore broader cooperation in digital asset infrastructure and on-chain liquidity services, indicating a strong intent for future collaboration.
- Potential Asset Acquisition: Under the MOU, CIMG may acquire certain assets, patents, and technologies from iZUMi, which could enhance CIMG's capabilities in managing its digital assets, particularly its Bitcoin holdings.
- Digital Asset Strategy: CIMG aims to evaluate new ways to manage and utilize its digital assets through this partnership, further driving growth in its digital health and sales development sectors.
- Client Portfolio Expansion: CIMG's client portfolio includes brands like Kangduoyuan and Maca-Noni, and this collaboration is expected to enhance its commercial value and market competitiveness by integrating iZUMi's services and IZI tokens.
See More
CIMG Enters Strategic Partnership MOU with iZUMi Finance
- Strategic Partnership MOU: CIMG has signed a memorandum of understanding with iZUMi Finance to explore extensive cooperation in digital asset infrastructure and on-chain liquidity services, indicating a strong intent for future collaboration between the parties.
- Potential Asset Acquisition: Under the MOU, CIMG may acquire certain assets, patents, and technologies from iZUMi, which would enhance CIMG's competitiveness in the digital health and sales development sectors.
- Digital Asset Management: CIMG intends to evaluate ways to manage and utilize its digital assets, including Bitcoin holdings, through this partnership, thereby increasing its commercial value and market position.
- Client Portfolio Expansion: CIMG focuses on leveraging AI and cryptocurrencies to drive business growth, with existing clients including several well-known brands, and future collaborations are expected to further expand its client base and market influence.
See More
CIMG Reports Significant Revenue Growth in FY 2025 Financial Results
- Significant Revenue Growth: CIMG achieved substantial revenue growth in FY 2025, driven by optimizing its business structure and focusing on two core sectors: AI computing infrastructure and digital health, demonstrating the effectiveness of the company's strategic transformation.
- Continued Reduction in Net Loss: The company reported a continued reduction in net loss during the reporting period, reflecting positive outcomes from the launch of new businesses and the progress of major contracts, alongside refined management practices.
- Digital Asset Strategy: CIMG plans to increase its Bitcoin holdings based on market conditions to strengthen corporate assets and core competitiveness, aiming to create sustainable value for shareholders, customers, and partners.
- Diverse Client Portfolio: The company's current client portfolio includes various brands such as Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango, showcasing its broad influence in the digital health and sales development sectors.
See More
CIMG Reports Significant Revenue Growth in FY 2025
- Significant Revenue Growth: CIMG reported approximately $10.3 million in revenue for FY 2025, reflecting a remarkable year-on-year increase of 433%, primarily driven by new computing power service contracts and its digital health business, indicating strong market performance.
- Substantial Reduction in Net Loss: The company's net loss decreased by approximately 45.5% year-on-year, showcasing the effectiveness of its business transformation and cost optimization efforts, which highlight significant progress in operational efficiency.
- Increased Digital Asset Reserves: As of September 30, 2025, CIMG held around 500 Bitcoins valued at approximately $57.05 million, contributing to a staggering 1,227% year-on-year increase in total assets, demonstrating the success of its digital asset strategy.
- Enhanced Shareholder Value: With a book value per share of approximately $2.99, combined with the company's strategic focus on AI computing infrastructure and digital health, it is expected to create sustainable value for shareholders, customers, and partners.
See More
